Therapeutic antibody expression technology
- 30 March 2001
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Biotechnology
- Vol. 12 (2), 188-194
- https://doi.org/10.1016/s0958-1669(00)00198-1
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Very high expression of an anti-carcinoembryonic antigen single chain Fv antibody fragment in the yeast Pichia pastorisJournal of Biotechnology, 2000
- Recent Progress in Biomolecular EngineeringBiotechnology Progress, 2000
- Functional transplant of megabase human immunoglobulin loci recapitulates human antibody response in miceNature Genetics, 1997
- Chimeric Anti-CD20 (IDEC-C2B8) Monoclonal Antibody Sensitizes a B Cell Lymphoma Cell Line to Cell Killing by Cytotoxic DrugsCancer Biotherapy & Radiopharmaceuticals, 1997
- Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".JCI Insight, 1996
- The structural requirements for complement activation by IgG: does it hinge on the hinge?Immunology Today, 1995
- Human immunoglobulin transgenes undergo rearrangement, somatic mutation and class switching in mice that lack endogenous IgMInternational Immunology, 1994
- Construction and initial characterization of a mouse-human chimeric anti-TNF antibodyMolecular Immunology, 1993
- A possible procedure for reducing the immunogenicity of antibody variable domains while preserving their ligand-binding propertiesMolecular Immunology, 1991
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975